Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the ...

The myelodysplastic syndromes (MDS ... indeterminate potential and its association with the incidence of myeloid neoplasms (MN) remains to be explored. Here, the authors suggest that heteroplasmy ...

A new thesis from Karolinska Institutet shows the effectiveness of flexible parametric survival models in modeling multiple ...

Improvements in Hematological Parameters and Quality of Life (QOL) with Elritercept (KER-050): Results from an Ongoing Phase 2 Trial in Participants with Lower-Risk (LR) Myelodysplastic Neoplasms ...

The models were tested ... The risk for COVID-19 hospitalization is low in adults with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), but these individuals have a high mortality ...

The models were tested in the context of myeloproliferative neoplasms, a group of chronic ... transformation to acute myeloid leukemia and myelodysplastic syndromes. In her thesis, doctoral ...

This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.

Imkeldi is supplied as a strawberry-flavored oral solution in a 140 mL, child-resistant, tamper-evident bottle.

Treatment-related myeloid neoplasms were present in 4 of our patients. The median time to diagnosis was 30 months.” Six non-relapse deaths occurred (16%), including progression of 2 cases of previous ...